Pecan Tree Allergy Shots (SCIT)
Pecan tree pollen is the most under-recognized major tree allergen in the South-Central US β 27.8% SPT positivity in US children with rhinitis (Hoffman 1996) and 27.1% reactivity in NYC tree-allergic patients (Bucholtz et al.), yet zero formally named pollen allergens at WHO/IUIS as of May 2026 and no SCIT RCT.
About Curexβs SCIT program
Curexβs at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- β’ Pollens β tree, grass, weed & ragweed
- β’ Pet dander β cat & dog
- β’ Dust mites
- β’ Molds β Alternaria & mold mix
Pecan Treeis covered here for general education and may not be part of Curexβs current treatment set. Join the waitlist and our care team will help confirm your options.
Pecan Tree Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to pecan tree β rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of pecan tree allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7β10 years.
There are two evidence-based forms of pecan tree immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course β the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of pecan tree extract in a clinic, escalating over 3β6 months until a maintenance dose is reached. Continued monthly for 3β5 years. Longest clinical track record for pecan tree allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50β100+ in-person clinic visits across the full course
- Or at home with no clinic visitsβ Curexβs Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing pecan tree extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home β no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription pecan tree immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots β protocol, efficacy data, side effects, and cost. If youβd rather skip the clinic and treat pecan tree allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Pecan Tree?
The biology, taxonomy, and clinical fingerprint of Pecan Tree β the foundation of how SCIT targets it.
Carya illinoinensis catkins release massive quantities of pollen in mid-April through May across the South-Central US β yet despite 27.8% SPT positivity in US rhinitis patients, no pollen allergen has been formally named at WHO/IUIS. The named Car i allergens are all from the pecan kernel (food), not the pollen.
- Scientific name
- Carya illinoinensis (Wangenh.) K.Koch
- Family
- JuglandaceaeWalnut family
- Type
- Deciduous tree pollen
- Native to
- South-central US (TX, OK, LA, AR, MS, AL, GA); cultivated south to FL and west to CA/AZ/NM
- Allergen proteins
- NO pollen-specific Carya allergen has been formally named at WHO/IUIS as of May 2026 β despite documented clinical relevance in 27.8% of US children with rhinitisCuevas-ZuvirΓa et al. (J Proteomics 2021) identified 17 IgE-binding pollen proteins in pecan by immunoproteomics β but none have received formal IUIS designationNamed Carya allergens are ALL kernel (food) proteins: Car i 1 (2S albumin, heat-stable), Car i 2 (vicilin, heat-stable), Car i 4 (11S legumin, heat-stable) β from C. illinoinensis (pecan) onlyCRITICAL: Pecan pollen SCIT does NOT treat Car i 1/2/4 kernel food allergy, which involves heat-stable storage proteins
- Particle size
- 43β53 ΞΌm
- Avoidance difficulty
- Nearly impossible
How Pecan Tree Allergy Presents
Symptoms by body system β useful for distinguishing Pecan Tree sensitivity from overlapping allergies and infections.
Respiratory (Pollen Inhalant Allergy)
- Sneezing and profuse rhinorrhea during mid-April through May pecan pollen season across the South-Central US
- Nasal congestion on high-pollen days in TX, OK, LA, AR, MS, AL, and GA β the core pecan belt
- Itchy, swollen nasal passages during the 4β6 week pecan catkin release season
- Asthma exacerbations in sensitized patients during peak pollen weeks
- Post-nasal drip and chronic cough from sustained high-pollen exposure in orchard-adjacent areas
Ocular
- Bilateral eye itching and watering during pecan pollen season in the South-Central US
- Conjunctival redness and swelling on high-pollen days
- Morning eyelid puffiness from overnight pollen settling
- Photophobia and reduced visual comfort during severe allergic conjunctivitis
Dermal
- POLLEN vs KERNEL DISTINCTION: If you experience tingling or mild oral symptoms when eating raw pecan, this may reflect a heat-labile PR-10 cross-reaction (linked to birch-family sensitization). If you experience systemic hives, throat tightening, or anaphylaxis after eating pecan, this is Car i 1/2/4 storage-protein food allergy β which pollen SCIT does NOT treat.
- Contact dermatitis from pecan tree sap or hulls (contact allergy, separate from pollen)
- Atopic dermatitis flares coinciding with pecan pollen season in susceptible patients
Systemic
- Fatigue and sleep disruption from pecan season allergy β compounding with concurrent oak exposure in the same AprilβMay window
- Impaired outdoor activity in the prime South-Central spring season
- Anxiety around pecan-containing foods if kernel storage-protein allergy co-exists (Car i 1/2/4 β requires strict avoidance and epinephrine carry)
- Diagnostic confusion between pecan pollen rhinitis and pecan kernel food allergy is extremely common and requires component testing
Pecan is the biggest tree-pollen allergy in Texas, Oklahoma, and the lower Mississippi that almost nobody talks about β Hoffman's data showed 27.8% of US children with rhinitis are skin-test positive to pecan. We have no Phase 3 trial and no IUIS-named pollen allergen, but the clinical magnitude in this region is on par with oak.
When & Where Pecan Tree Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: mid-April through May across the South-Central US pecan belt (TX, OK, LA, AR, MS, AL, GA)Β· ~4β6 weeks; overlaps substantially with oak season in the South-Central US
US Exposure Map
5 high-intensity statesExposure intensity by state (text version)
- ME:
- None
- VT:
- None
- NH:
- None
- WA:
- Low
- MT:
- None
- ND:
- None
- MN:
- None
- WI:
- None
- MI:
- None
- NY:
- None
- MA:
- None
- OR:
- Low
- ID:
- None
- WY:
- None
- SD:
- None
- IA:
- None
- IL:
- Low
- IN:
- Low
- OH:
- None
- PA:
- None
- NJ:
- None
- CT:
- None
- RI:
- None
- CA:
- Moderate
- NV:
- None
- UT:
- None
- CO:
- Low
- NE:
- None
- MO:
- Moderate
- KY:
- None
- WV:
- None
- VA:
- Low
- MD:
- None
- DE:
- None
- AZ:
- Moderate
- NM:
- Moderate
- KS:
- Moderate
- AR:
- High
- TN:
- Moderate
- NC:
- Low
- SC:
- Low
- OK:
- High
- LA:
- High
- MS:
- High
- AL:
- Moderate
- GA:
- Moderate
- TX:
- High
- FL:
- Moderate
- AK:
- None
- HI:
- None
What Pecan Tree Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Pecan pollen cross-reactivity within Carya is essentially complete β intra-genus pollen immunology is treated as a single unit in clinical SCIT practice. Cross-reactivity with walnut (Juglans) at the pollen level is inferred from family-level Juglandaceae homology but has not been formally characterized because no pollen allergen has been named for any Carya species.
Combined Carya SCIT mix β built on this near-complete within-genus cross-reactivity
Pecan Kernel vs Pecan Pollen β Two Different Allergies
Pecan kernel food allergy driven by Car i 1 (2S albumin), Car i 2 (vicilin), and Car i 4 (11S legumin) involves heat-stable proteins that can cause anaphylaxis and require strict avoidance and epinephrine carry. This is entirely separate from pecan pollen inhalant allergy. Pecan pollen SCIT does not desensitize Car i 1/2/4 kernel food allergy. A board-certified allergist should perform component-resolved testing to identify which mechanism applies before any treatment decision.
Is SCIT Right for Your Pecan Tree Allergy?
Answer five questions to assess whether pecan tree pollen SCIT is appropriate for your South-Central US spring allergy profile.
How severe are your spring symptoms during pecan pollen season (AprilβMay) in the South-Central US?
The Pecan Tree SCIT Protocol
Pecan pollen SCIT uses non-standardized C. illinoinensis extract, often maintained at 1:100 to 1:50 w/v in regional southern Mix B/Mix C combinations where pecan is the dominant clinical allergen. No SCIT RCT exists for pecan pollen, and no pollen-specific allergen is named at WHO/IUIS.
Injections begin at 1:100,000 w/v β more conservative than the textbook 1:10,000 default β and increase incrementally. South-Central US patients should ideally start build-up in fall or winter β well before the mid-April pecan pollen release β to reach maintenance before the peak. Patients with confirmed pecan kernel food allergy (Car i 1/2/4) must continue strict kernel avoidance and carry an epinephrine auto-injector throughout SCIT. With at-home SCIT through Curex, the first injection from each new vial or concentration is supervised live in the Virtual Shot Room by trained Curex clinical staff, with a prescribed epinephrine auto-injector confirmed on hand and a 30-minute self-observation after each injection.
Ongoing maintenance at the target dose. In regions where pecan is the dominant spring tree allergen (TX, OK, LA), some allergists push the maintenance dose to 1:50 in regional Mix B/Mix C combinations for greater clinical effect. This practice is based on clinical observation, not formal RCT data.
Lasting benefit of 7β12+ years expected with full course completion. SCIT discontinuation has no impact on kernel food allergy management β strict avoidance and epinephrine carry continue indefinitely for patients with Car i 1/2/4 sensitization.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Pecan Tree SCIT
Pecan pollen SCIT has no species-specific RCT and no formally named pollen allergen. Efficacy must be honestly characterized as extrapolated from general inhalant SCIT principles, with the Hoffman 1996 and Bucholtz sensitization data providing the strongest evidence that pecan is a clinically significant aeroallergen warranting treatment.
- SPT positivity in US children with rhinitis (clinical magnitude proxy)28%Hoffman 1996 (cited Thermo Fisher t22): 27.8% SPT-positive in 209 US children with rhinitis
- Reactivity in NYC tree-allergic patients27%Bucholtz et al. NYC series: 27.1% of 371 tree-allergic patients reacted to pecan/hickory pollen
- General inhalant SCIT efficacy for non-standardized tree pollen55%Cox L et al., J Allergy Clin Immunol 2011 β AAAAI Practice Parameter general framework
No SCIT RCT exists for pecan pollen, and no WHO/IUIS-named pollen allergen has been characterized for C. illinoinensis despite its clinical prominence (27.8% SPT positivity per Hoffman 1996). The Cuevas-ZuvirΓa 2021 immunoproteomics study identified 17 IgE-binding pollen proteins β establishing a biological basis for clinical sensitization β but formal allergen designation requires additional characterization. Pecan SCIT is a standard component of southern Mix B/Mix C regional immunotherapy mixes despite the absence of species-specific RCT data.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Pecan Tree SCIT Side Effects
Pecan pollen SCIT side effects follow the standard inhalant SCIT profile. South-Central US patients should start build-up in fall or winter to minimize the reactivity risk from active pecan pollen co-exposure during AprilβMay titration.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site swelling Expected during build-up; resolves within 24 hours | Rate 30β50% | Mild |
Injection-site itching Ice and pre-treatment antihistamine recommended | Rate 20β40% | Mild |
Large local reaction (>25 mm) Higher during active pecan pollen season; fall/winter build-up start preferred | Rate 5β10% | Moderate |
Persistent redness and warmth Resolves within 24 hours | Rate 10β20% | Mild |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Rhinitis/conjunctivitis flare Sneezing or eye watering within minutes to 1 hour; antihistamine responsive | Rate 0.5β1% | Mild |
Urticaria Generalized hives; managed with antihistamines Β± epinephrine | Rate 0.1β0.5% | Moderate |
Bronchospasm Higher risk in asthmatic patients; spirometry before SCIT recommended | Rate 0.1β0.3% | Moderate |
Anaphylaxis Rare at properly titrated doses; a prescribed epinephrine auto-injector is confirmed on hand and a 30-minute self-observation follows every dose; for at-home SCIT through Curex the first injection from each new vial or concentration is supervised live in the Virtual Shot Room by trained Curex clinical staff | Rate <0.01% | Severe |
CRITICAL: Patients with confirmed pecan kernel food allergy (Car i 1, Car i 2, or Car i 4 IgE-positive) must continue strict kernel avoidance and carry an epinephrine auto-injector throughout and after pollen SCIT. Pollen immunotherapy does not reduce the risk of anaphylaxis from eating pecan kernels. A 30-minute self-observation follows every pecan SCIT dose; with at-home SCIT through Curex the serum is sterile-compounded to USP <797>, a prescribed epinephrine auto-injector is confirmed on hand, and the first injection from each new vial or concentration is supervised live in the Virtual Shot Room by trained Curex clinical staff.
SCIT vs Alternatives for Pecan Tree
Pecan-pollen-allergic patients in the South-Central US have four main options for the inhalant component: SCIT, at-home sublingual drops, avoidance (difficult in pecan-belt states), and daily seasonal medications. Kernel food allergy management is entirely separate.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Uncertain but clinically used β no pecan-specific RCT; standard inhalant SCIT evidence applies | Uncertain β no pecan pollen SLIT RCT; off-label drops used clinically | Low-moderate β difficult in TX/OK/LA where pecan is ubiquitous in the landscape | Moderate β antihistamines + nasal corticosteroids for mild-to-moderate symptoms |
| 5-yr cost | $3,500β$15,000 over 5 years | Varies by provider (off-label sublingual drops β not Curex; Curex delivers at-home SCIT shots) | Low β HEPA, pollen masks, closed windows | $500β$2,000 over 5 years |
| Duration | 3β5 year course | 3β5 year course | Indefinite β no tolerance change | Indefinite β seasonal use |
| Convenience | Weekly at-home self-injection with Curex; fall/winter start preferred; the first injection from each new vial or concentration supervised live in the Virtual Shot Room | Daily at-home β no clinic required | High inconvenience during prime spring season in pecan belt | High convenience |
| Safety | Excellent with a prescribed epinephrine auto-injector on hand, a 30-min self-observation, and live Zoom supervision of every dose change (pollen SCIT only; kernel allergy risks unchanged) | Favorable for pollen; does not affect kernel food allergy risk | Safe | Generally safe |
| Lasting effect | 7β12+ years after completion | Emerging data | None β symptoms return each April | None β must take every season |
SCITBest
SLIT
Avoidance
Medications
SCIT anchored to pecan and other Carya species is the standard immunotherapy approach for South-Central US patients with documented pecan pollen sensitization β using the Hoffman 1996 and Bucholtz clinical magnitude data as justification even in the absence of a pecan-specific RCT. Curex now offers this as a weekly at-home allergy shot with pricing confirmed in a current program quote, with a serum sterile-compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand, and the first injection from each new vial or concentration supervised live in the Virtual Shot Room by trained Curex clinical staff. Sublingual drops remain a general allergy modality some providers offer for patients who prefer a needle-free option.
What Pecan Tree SCIT Actually Costs
Pecan pollen SCIT is covered by most major US insurers under standard allergy immunotherapy benefits when ordered by a board-certified allergist with documented sensitization (positive skin prick test or specific IgE to pecan pollen extract). Pecan is typically included as part of a southern multi-tree mix β pre-authorization should specify the full extract composition including all Carya and Juglandaceae components. Curex at-home IgE testing identifies specific pecan tree sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your pecan tree allergy. Get a plan.
Take Curexβs 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you β shots or drops.
Free quiz Β· Board-certified allergists Β· 50,000+ patients treated Β· HSA/FSA eligible
Pecan Tree SCIT β Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Yes β pecan is one of the most clinically significant spring tree allergens in the South-Central US, including Texas, Oklahoma, Louisiana, Arkansas, and Mississippi. The Hoffman 1996 study, cited by Thermo Fisher in their pecan allergen profile (t22), documented 27.8% SPT positivity to pecan in 209 US children evaluated for rhinitis β a sensitization rate comparable to the most prominent US tree allergens. The Bucholtz NYC series of 371 tree-allergic patients showed 27.1% reactivity to pecan/hickory pollen. Despite this clinical magnitude, pecan is under-discussed in national allergy education compared with oak, birch, and ragweed β partly because it lacks a named IUIS pollen allergen and a Phase 3 SCIT trial.
No. Pecan kernel food allergy is driven by heat-stable storage proteins Car i 1 (2S albumin), Car i 2 (vicilin), and Car i 4 (11S legumin) β proteins found in the kernel, not the pollen. Pecan pollen SCIT uses a pollen extract that does not contain these kernel storage proteins, and therefore has no desensitizing effect on Car i 1/2/4-mediated food reactions. Patients with confirmed Car i 1/2/4 sensitization must continue strict pecan kernel avoidance and carry an epinephrine auto-injector regardless of whether they are on pollen SCIT. The two allergies β pollen inhalant and kernel food β require entirely separate management strategies.
The absence of a named IUIS pollen allergen for Carya is an acknowledged gap in the allergen nomenclature. The IUIS naming process requires formal protein isolation, sequencing, and peer-reviewed publication. Cuevas-ZuvirΓa et al. (J Proteomics 2021) took an important step by identifying 17 IgE-binding proteins in pecan pollen via immunoproteomics, but formal IUIS designation requires additional characterization and submission. The research focus for Carya allergens has historically been on kernel proteins (Car i 1/2/4) because pecan food allergy carries a higher anaphylaxis burden than pollen allergy, making it a higher research priority globally. Pollen allergy research in Carya remains underfunded relative to the clinical magnitude in the US South-Central region.
Likely yes for hickory (within Carya genus), and possibly for walnut (Juglandaceae cross-genus). Within the Carya genus, pollen cross-reactivity is reported as essentially complete in clinical practice β patients who test positive to pecan pollen typically also react to hickory pollen (shagbark, mockernut, bitternut) via shared pollen proteins. Across genera (Carya to Juglans), moderate cross-reactivity at the kernel level has been documented via storage-protein homology, and some pollen-level cross-reactivity is also assumed from family-level immunological relatedness. This is why the combined hickory-pecan SCIT mix is the standard Juglandaceae formulation β one extract covers the full Carya genus and provides some Juglandaceae family-level coverage.
A fall or winter start β September through January β is ideal for pecan SCIT patients in the South-Central US. This gives 4β7 months of weekly build-up to reach or approach maintenance dose before the mid-April pecan pollen release. Starting build-up during active AprilβMay pecan season increases the risk of larger local reactions and systemic reactions at each dose increment, because active airborne pollen exposure sensitizes the immune system simultaneously with the injections. Discuss timing with a board-certified allergist well before the season β planning 6 months in advance is the standard recommendation.
Yes, antihistamines are generally compatible with pecan SCIT. Many allergists recommend taking a non-sedating antihistamine on injection days to reduce local swelling at the injection site. However, antihistamines can mask early signs of systemic reactions β so you should always inform the clinic about your current medications before each injection visit. Do not use antihistamines specifically to hide systemic symptoms so you can proceed with an injection without informing the nurse β this is unsafe. Nasal corticosteroids do not interfere with immunotherapy and should be continued as directed throughout the course.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs β including the parts that are not flattering.